Rapamycin and its derivatives for the treatment of liver-associated fibrosing disorders

Details for Australian Patent Application No. 2007287809 (hide)

Owner Novartis AG

Inventors Tsai, Ruey-Shiuan

Agent Davies Collison Cave

Pub. Number AU-A-2007287809

PCT Pub. Number WO2008/022761

Priority 06121903.6 06.10.06 EP; 06119311.6 22.08.06 EP

Filing date 20 August 2007

Wipo publication date 28 February 2008

International Classifications

A61K 31/436 (2006.01)

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

5 March 2009 PCT application entered the National Phase

  PCT publication WO2008/022761 Priority application(s): WO2008/022761

26 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007287811-Chain tensioning device

2007287807-Specific and high affinity binding proteins comprising modified SH3 domains of FYN kinase